While no curative treatment exists for multiple sclerosis (MS), several disease-modifying
therapies (DMTs) have been developed to reduce relapse rates, slow disability progression …

Impact of Diagnosis and Early Treatment on the Course of Multiple Sclerosis Page 1 VOL. 19, NO.
17 ■ THE AMERICAN JOURNAL OF MANAGED CARE ■ S321 Multiple sclerosis (MS), a …

Importance Comparative real-world effectiveness studies of initial disease-modifying
treatment (DMT) choices for relapsing-remitting multiple sclerosis (RRMS) that include …

Objective: Achieving therapeutic goals in multiple sclerosis (MS) requires strict adherence to
treatment schedules. This retrospective study analyzed persistence with, and adherence to …

Relapse in multiple sclerosis | The BMJ Skip to main content Intended for healthcare
professionals Access provided by Google Indexer Subscribe My Account My email alerts BMA …

Objective We aimed to estimate the prevalence and predictors of optimal adherence and
persistence to the disease-modifying therapies (DMT) for multiple sclerosis (MS) in 3 …

Background Several disease-modifying drug therapies are available for the treatment of
multiple sclerosis (MS). To ensure the most appropriate MS management, we assessed the …

Multiple sclerosis (MS) is primarily an autoimmune disease of the central nervous system,
but also encompasses prominent neurodegenerative aspects. A significant proportion of MS …

Introduction Nearly 50% of patients with chronic medical illness exhibit poor treatment
adherence. When making treatment decisions, these patients must balance the probability of …

Background: Adherence to disease-modifying therapies (DMTs) in pediatric multiple
sclerosis (MS) is not well understood. We examined the prevalence and risk factors for poor …